Jan 24th, 2024
Today's Late-Breaking Science
Four presentations will highlight today's Late-Breaking Science.
Thursday Main Event | 11 a.m.-12:30 p.m. | Main Event Hall, Halls 1-3
- Intravenous Tirofiban Reduces Early Neurological Deterioration in Acute Ischemic Stroke: The Trend Randomized Controlled Clinical Trial
- Uric Acid Supplementation Provides Cerebroprotection Across Different Animal Species, Sex, Age and Comorbidities: A Report From the Stroke Preclinical Assessment Network (SPAN)
- Rescue on Reperfusion Damage in Cerebral Infarction by Nelonemdaz: A Phase 3 Trial
- Effect of an Artificial Intelligence-Based Clinical Decision Support System on Stroke Care Quality and Outcomes in Patients With Acute Ischemic Stroke (Golden Bridge II): A Cluster-Randomized Clinical Trial
